Tracey O’Shea: We are still using MegaSporeBiotic for some protocols/patients, especially if the patient has had trouble tolerating probiotics in the past. In general though, the SEED probiotic has been replacing both MSB and Prescript Assist in the protocols. We use TerraFlora for maintenance probiotics after protocol more than during the protocol.
- Home
- Knowledge Base
- General Functional Medicine
- I see the course content was updated to reflect Seed replacing Prescript-Assist. Does TerraFlora then replace MegaSpore Biotic? (generally)
- Home
- Knowledge Base
- Gut Health
- I see the course content was updated to reflect Seed replacing Prescript-Assist. Does TerraFlora then replace MegaSpore Biotic? (generally)
- Home
- Knowledge Base
- Supplements
- I see the course content was updated to reflect Seed replacing Prescript-Assist. Does TerraFlora then replace MegaSpore Biotic? (generally)
I see the course content was updated to reflect Seed replacing Prescript-Assist. Does TerraFlora then replace MegaSpore Biotic? (generally)
Related Articles
- This is a case, “[There’s] a 60-year-old with chronic urticaria, dermatographia, receiving periodic steroids, [with] acute severe itching and scratching on [their] legs and arms. [They] had Viome testing, [which was] normal for the most part. How does this test compare with [the] Doctor’s Data test?”
- Do you test for hypochlorhydria and pancreatic enzyme insufficiency? Is stool testing of pancreatic elastase a reliable method?
- When labs indicate intestinal permeability and microbial infection, what’s your approach to clearing and repairing? I assume you measure these with Cyrex 2 and 12, respectively.
- With the increased consumption of kombucha, do we tell patients to avoid, if they have sensitivity to yeast, Saccharomyces cerevisiae, or is the SCOBY a different yeast not to be concerned about?
- Even if a patient is a wheat consumer, would you test for intestinal permeability prior to running the Cyrex 3 panel?
- Is a healthy and stable gut microbiome difficult and possible to risk among the following types of patients: (1) people in the study that I mentioned in which three or more generations on a low-fiber diet led to permanent loss of key microbes; (2) individuals that have never been colonized normally, like people who were born [via] a C-section or [were] formula-fed; (3) individuals whose mucosal microbiome and immune system vigilantly exclude newcomers resulting in unsuccessful causation [2:47] of probiotics.